Hemostemix to Present at Life Science Investor Forum
Newsfile·2025-09-17 11:52
Hemostemix to Present at Life Science Investor ForumSeptember 17, 2025 7:52 AM EDT | Source: Hemostemix Inc.Calgary, Alberta--(Newsfile Corp. - September 17, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company offering VesCell™ (ACP-01) to individuals suffering from peripheral arterial disease, chronic limb threatening ischemia, angina, ischemic cardiomyopathy, non-ischemic dilated cardiomyopathy, congestive heart fai ...